Another approval for Novartis’ everolimus
February 18, 2013Sales and Marketing Certican, Novartis, Zortress, everolimus
Novartis has gained US approval for its drug Zortress (everolimus) to prevent liver transplant rejection.Zotress is already used to prevent …
Insulin blockbusters targeted by biosimilar blitz
February 15, 2013Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin
Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …
Janssen launches dementia prize
February 15, 2013Sales and Marketing Hunt, Janssen, NHS, dementia
Janssen has joined forces with the NHS to launch a scheme to financially reward solutions which can help the lives …
Fundraising to fuel e-Therapeutics’ ‘network pharmacology’
February 15, 2013Research and Development e-Therapeutics
Drug discovery and development firm e-Therapeutics hopes to raise £40 million via a new share offer to fund its research …
Lancet sparks agency row
February 15, 2013Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris
Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …
Nanobiotix appoints ex-Sanofi head Alain Herrera
February 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix
Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …
BMS hires Ann Powell Judge from Shire
February 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire
BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …
Shire ADHD drug for UK
February 14, 2013Sales and Marketing ADHD, Shire, Vyvanse, elvanse
Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …
Delivering value in cost-constrained healthcare environments
February 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value
As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …
BMS in $438m OTC deal
February 14, 2013Sales and Marketing BMS, Reckitt Benckiser
Bristol-Myers Squibb has signed over the rights to sell, distribute and market half a dozen of its medicines, mainly sold …
Universal WorldEvents creates dedicated training role
February 14, 2013Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents
Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …
NICE rejects Jakavi
February 13, 2013Sales and Marketing Jakavi, NICE
NICE has today issued draft guidance saying it does not recommend Novartis’ Jakavi for patients with myelofibrosis, a rare blood …
Ironwood announces new president of R&D
February 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Ironwood
Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …
Sanofi ups stake in Regeneron
February 13, 2013Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap
Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …
Shire pays Impax $48 million
February 12, 2013Sales and Marketing ADHD, Adderall, Impax, Shire
Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …
Perrigo buys Rosemont for £180 million
February 12, 2013Manufacturing and Production Perrigo, Rosemont
UK-based Rosemont Pharmaceuticals has been sold by its private equity owner to Perrigo of the US in a £180 million …
Mylan appoints two heads to Board of directors
February 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan
Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …
FDA rejects Novo diabetes drugs
February 12, 2013Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba
The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …
Merck planning more manufacturing cutbacks?
February 11, 2013Manufacturing and Production Merck, restructuring
Merck & Co has said it intends to make additional reductions to its manufacturing network, although the pace of restructuring …
FDA offers Alzheimer’s guidance
February 11, 2013Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly
The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
